Based on these findings, clinical recommendations include routine NT-proBNP assessment in HF, severe COVID-19, and pulmonary hypertension, as well as the incorporation of troponin monitoring in ARDS management to detect myocardial injury. The gene discussed is NPPB; the disease is acute respiratory distress syndrome.